Selexis SA to Present New Data on MARtech™ at the BioProcess International, European Conference and Exhibition
Data Will Elucidate the Mechanism Behind MARtech™
Geneva, Switzerland – February 13, 2006 - Selexis SA, a Swiss-based biotechnology company specializing in high yield and stable cell line development for therapeutic protein manufacturing announced today that it will release new data from FISH analysis of CHO cell lines expressing recombinant proteins at the next BioProcess International, European Conference and Exhibition in Prague, Czech Republic (February 21-22, 2006).
Dr. Cori Gorman, Ph.D., M.B.A., will present these FISH data which will elucidate the mechanism behind MARtech™ on Tuesday, February 21, 2006 at 2:30 PM as part of the Cell Culture and Upstream Processing track. Selected slides from the lecture, including data on MARtech™, will also be available following the meeting.
Selexis' patented technology, MARtech™, improves the speed, yield and stability of production cell lines used for therapeutic protein manufacturing. MARtech™ allows fast cell population generation in 3 weeks (after transfection) and stable cell line development in 8 weeks (after transfection to first round of cell cloning). Additionally, MARtech™ has been found to increase recombinant protein expression in mammalian cells in suspension and in serum-free more than 10 fold.
About BioProcess International, European Conference and Exhibition
BioProcess International Conference and Exhibition is a collaboration between IBC’s four
successful biopharmaceutical development conferences and BioProcess International, the first
and only international publication devoted to the development, scale-up, and manufacture of
biotherapeutics and biodiagnostics. The conference is the premier event for a comprehensive
update on operational strategies, technologies, regulatory changes, manufacturing production,
and process development. The conference consists of four in-depth tracks: 1 - Scaling-up,
Economics and Manufacturing Strategies; 2 - Formulation & Drug Delivery; 3 - Cell Culture &
Upstream Processing; and 4 - Recovery & Purification.
For more information, please visit
www.ibc-lifesci.com/bpi/2006